These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1799959)

  • 1. Understanding multiple sclerosis: new immunologic insights and prospects for specific therapy.
    Ransohoff RM
    Compr Ther; 1991 Nov; 17(11):3-6. PubMed ID: 1799959
    [No Abstract]   [Full Text] [Related]  

  • 2. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
    Miller A; Weiner HL; Abramsky O
    Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapy of multiple sclerosis: "T-cell vaccination"].
    Zipp F; Hohlfeld R
    Nervenarzt; 1994 Jun; 65(6):424-5. PubMed ID: 8072598
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor: immunogenetics and disease.
    Hauser SL
    Ann Neurol; 1995 Nov; 38(5):702-4. PubMed ID: 7486860
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects of an immunologic therapy of multiple sclerosis].
    Fasanaro G; Gentile A; Stella L
    Acta Neurol (Napoli); 1972; 27(4):367-78. PubMed ID: 5085161
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunospecific drug design--prospects for treatment of autoimmune diseases.
    Arnon R; Teitelbaum D
    Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy. Wielding worms at asthma and autoimmunity.
    Wickelgren I
    Science; 2004 Jul; 305(5681):171. PubMed ID: 15247452
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease.
    Hafler DA; Weiner HL
    Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525
    [No Abstract]   [Full Text] [Related]  

  • 15. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model.
    McFarland HF
    J Clin Invest; 1994 Sep; 94(3):921-2. PubMed ID: 8083376
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
    Cohen Y; Nagler A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
    Zhang J
    Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.